Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron. Web editor Nicole Raleigh speaks with Rob Abbott ...

Independent news. Trusted by Texans. Support us. By Sofia Sorochinskaia May 13, 2025 Student discipline, uncertified teachers and school bans on DEI and cellphones are some of the topics being ...